20-35871703-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_016436.5(PHF20):c.1156C>T(p.His386Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000756 in 1,613,770 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016436.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PHF20 | NM_016436.5 | c.1156C>T | p.His386Tyr | missense_variant | 9/18 | ENST00000374012.8 | NP_057520.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PHF20 | ENST00000374012.8 | c.1156C>T | p.His386Tyr | missense_variant | 9/18 | 1 | NM_016436.5 | ENSP00000363124.3 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152122Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000836 AC: 21AN: 251198Hom.: 0 AF XY: 0.0000737 AC XY: 10AN XY: 135764
GnomAD4 exome AF: 0.0000787 AC: 115AN: 1461530Hom.: 0 Cov.: 31 AF XY: 0.0000715 AC XY: 52AN XY: 727076
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152240Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74446
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 20, 2024 | The c.1156C>T (p.H386Y) alteration is located in exon 9 (coding exon 8) of the PHF20 gene. This alteration results from a C to T substitution at nucleotide position 1156, causing the histidine (H) at amino acid position 386 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at